Get 10% off PSL Alliance membership - Join by 31st July 2024

Sell Side

Our specialist M&A team brings collective skills & experience of over 80 years within the biotech sector

Alliance 1
Pivotal Links 2019

Selling a biotech company

Once you have decided that your exit route is to sell your company or merge with a larger entity, we are able to support you within the widest possible selection of scenarios. Our projects are fully modular and we offer end-to-end support as well as individual activities on a standalone basis. We provide a full suite of advisory services including:

  • Valuation services (including value creation planning).
  • Feasibility studies (how to get ‘fit for purpose’).
  • Business planning including full strategic support for future sales and long-range planning (a model to implement and to present to potential investors).
  •  Identification of potential buyers
Sell Side Infographic